Related references
Note: Only part of the references are listed.Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China
Terry Cheuk-Fung Yip et al.
GASTROENTEROLOGY (2020)
Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants
Shuijing Wang et al.
PHARMACOLOGICAL RESEARCH (2020)
Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
Tracey G. Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Increasing antiviral treatment uptake improves survival in patients with HBV-related HCC
Vicki Wing-Ki Hui et al.
JHEP REPORTS (2020)
Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Teng-Yu Lee et al.
JAMA INTERNAL MEDICINE (2019)
Uncovering the mechanism of action of aspirin in HCC chemoprevention
Natascha Roehlen et al.
EBIOMEDICINE (2019)
Long-term use of low-dose aspirin for cancer prevention: A 10-year population cohort study in Hong Kong
Kelvin K. F. Tsoi et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines
Francis K. L. Chan et al.
GUT (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Association Between Aspirin Use and Risk of Hepatocellular Carcinoma
Tracey G. Simon et al.
JAMA ONCOLOGY (2018)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
Infection and Cancer: The Case of Hepatitis B
Stephen L. Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies
Luis A. Garcia Rodriguez et al.
PLOS ONE (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B-A Nationwide Cohort Study
Chun-Ying Wu et al.
GASTROENTEROLOGY (2014)
Prognostic score-based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research
Elizabeth A. Stuart et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
A tutorial on propensity score estimation for multiple treatments using generalized boosted models
Daniel F. McCaffrey et al.
STATISTICS IN MEDICINE (2013)
Comparison of imputation methods for missing laboratory data in medicine
Akbar K. Waljee et al.
BMJ OPEN (2013)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Long-Term Use of Aspirin and the Risk of Gastrointestinal Bleeding
Edward S. Huang et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Imputing missing covariate values for the Cox model
Ian R. White et al.
STATISTICS IN MEDICINE (2009)
Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples
Peter C. Austin
STATISTICS IN MEDICINE (2009)
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies
Enrico Flossmann et al.
LANCET (2007)
Indications for propensity scores and review of their use in pharmacoepidemiology
RJ Glynn et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2006)
Share Paper
